Caladrius Biosciences, Inc. (CLBS): Price and Financial Metrics

Caladrius Biosciences, Inc. (CLBS): $6.40

1.26 (-16.44%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add CLBS to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#259 of 449

in industry

CLBS Price/Volume Stats

Current price $6.40 52-week high $9.75
Prev. close $0.51 52-week low $0.38
Day low $5.73 Volume 1,796,440
Day high $9.75 Avg. volume 522,308
50-day MA $0.52 Dividend yield N/A
200-day MA $0.65 Market Cap 387.49M

CLBS Stock Price Chart Interactive Chart >


Caladrius Biosciences, Inc. (CLBS) Company Bio


Caladrius Biosciences, Inc., formerly NeoStem, Inc., through its subsidiary, PCT, LLC, a Caladrius Company (PCT), provides development and manufacturing services to the cell therapy industry (which includes cell-based gene therapy). PCT specializes in cell and cell-based gene therapies.


CLBS Latest News Stream


Event/Time News Detail
Loading, please wait...

CLBS Latest Social Stream


Loading social stream, please wait...

View Full CLBS Social Stream

CLBS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -55.56%
5-year -84.43%
YTD N/A
2023 N/A
2022 0.00%
2021 -41.15%
2020 -43.03%
2019 -29.49%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!